[Valutazione dell'attitudine alla correlazione anatomo-clinica in patologia pediatrica]

[Valutazione dell’attitudine alla correlazione anatomo-clinica in patologia pediatrica]

Antibody, Armenia, Asia, Asie, Assay Kit, at, Australia, Austria, Azie, B, BE, Belgium, BG, Blog, Brussels Belgium, Buffer, Bulgaria, Bulgarije, canada, cDNA, Cells, ch, Chile, China, CN, Comparison of Intranasal Dexmedetomidine and Oral Midazolam for Premedication in Pediatric Dental Patients under General Anesthesia: A Randomised Clinical Trial., cz, czech rep, de, denmark, dk, DNA, Elisa Kit, Enzyme, ES, estonia, finland, FR, france, Francia, GB, gb/ch, Gel, Germania, GR, HK, ierland, IL, IN, India, iran, Isolation Kit, israel, it, italy, japan, jp, Kit, Korea, kr, Lab Product, Lab Reagent, latvia, Lentivirus, Lentivirus Vector, malaysia, Media, Medium, NATtrol, nederland, NL, no, Particles, Protein, qPcr Kit, Reagent, Recombinant Protein, RNA, SE, Serum, SG, Solution, South Korea, spain, Stain, sweden, switserland, taiwan, United States, Utility of clinical exome sequencing in a complex Emirati pediatric cohort. / By

Nel XVIII secolo, Giovanni Battista Morgagni dimostrò che lesioni localizzate a diversi organi causavano una grande varietà di sintomi e segni clinici. Da allora, la pratica medica si è evoluta notevolmente e mantiene la correlazione dei cambiamenti patologici con i segni e sintomi della malattia nell’ambito dell’attività accademica nota come “seduta anatomico-clinica”. La valutazione dell’attitudine alla correlazione anatomico-clinica non è stata stimata empiricamente in patologia pediatrica.

costruire e validare uno strumento di valutazione per stimare quantitativamente l’attitudine alla correlazione anatomico-clinica nella patologia pediatrica (AA-CCPP). studio analitico trasversale. È stato costruito uno strumento di valutazione con 90 affermazioni vero, falso e non so tipo, raggruppate in base a tre indicatori: I, integrazione diagnostica; II, identificazione di meccanismi patogeni e III, identificazione di dati clinici e paraclinici. Lo strumento è stato applicato a tre gruppi di residenti.

Il test Kruskal-Wallis è stato utilizzato per confrontare i risultati tra i gruppi. il grado AA-CCPP era molto basso nella maggior parte dei residenti. Quando si confrontano i punteggi globali tra i diversi gruppi, il gruppo di patologia pediatrica era il più alto. L’indicatore che ha ottenuto i migliori risultati è stato quello dell’Integrazione Diagnostica. Conclusioni: il livello di sviluppo dell’AA-CCPP osservato ci consente di dedurre che la strategia di apprendimento nota come conferenza clinico-patologica dovrebbe essere rafforzata.

Due chirurghi ortopedici pediatrici sono stati osservati individualmente e le attività sono state programmate durante 3 sessioni cliniche. Uno studente di medicina ha osservato e registrato l’ora utilizzando un foglio di raccolta dati e un orologio. La durata di ogni sessione clinica è stata di 4 ore e un nuovo paziente è stato visitato ogni 20 minuti. I dati sono stati raccolti in 7 categorie tra cui: tempo con il paziente; tempo con il personale; tempo di ascolto delle presentazioni dei residenti, tempo di insegnamento, tempo di multitasking, dettatura del tempo e tempo sulla cartella clinica elettronica (EMR).

Cambiamenti nell’ansia e nella depressione dall’assunzione al primo follow-up tra i giovani transgender in una clinica di endocrinologia pediatrica

 

Il monitoraggio del disagio acuto nei giovani transgender che iniziano cure che affermano il genere è importante dato il loro aumentato rischio di sintomi di salute mentale significativi. L’attuale studio ha esaminato i cambiamenti nell’ansia, nella depressione e nella tendenza al suicidio dall’appuntamento iniziale al primo follow-up in 80 giovani, di età compresa tra 11 e 18 anni. Il tempo medio tra le visite era di ∼4 mesi, ma variava tra i partecipanti.

I risultati non hanno rivelato alcun cambiamento nel disagio acuto dall’assunzione al follow-up. Né la distanza dal centro medico né l’inizio della terapia ormonale sono stati associati a cambiamenti dei sintomi. Mentre la ricerca mostra una diminuzione del disagio con l’inizio degli ormoni, i risultati dello studio suggeriscono che i cambiamenti potrebbero effettivamente richiedere più tempo per verificarsi.

27 pazienti hanno soddisfatto i criteri di inclusione con un’età media di 11,2 anni e una ripartizione razziale dell’85,2% (23) bianco, 11,1% (3) nero e 3,7% (1) multirazziale. Cicatrici cliniche sono state osservate nella maggior parte (23, 85,2%). La biopsia ha confermato la diagnosi nella maggior parte dei casi (24, 88,9%). Le diagnosi più comuni erano follicolite decalvans (6, 22,2%), lichen planopilaris (6, 22,2%), aplasia cutis congenita (4, 14,8%), tinea capitis (4, 14,8%) e morfea (3, 11,1%) . La depressione in comorbidità (6, 22,2%) e l’ansia (6, 22,2%) erano prevalenti.

Tra i pazienti che hanno ricevuto il follow-up, la maggior parte di coloro che hanno seguito il trattamento ha raggiunto la stabilizzazione (55,5%) o il rallentamento della progressione (27,8%), con il 44,4% di quelli trattati che hanno sperimentato la ricrescita. Il tempo medio per la stabilizzazione nella popolazione trattata è stato di 19,6 mesi. Due pazienti non hanno proseguito il trattamento, ma hanno ricevuto un follow-up e questi pazienti non trattati non hanno avuto la ricrescita dei capelli.

[Valutazione dell'attitudine alla correlazione anatomo-clinica in patologia pediatrica]

Esperienza di iniezioni di tossina botulinica A per l’emicrania cronica in una clinica pediatrica per il dolore cronico

 

La prevalenza dell’emicrania cronica nei bambini può raggiungere il 7,7%, causando una riduzione del rendimento scolastico, difficoltà con attività extracurriculari (inclusi sport, teatro o musica) e cambiamenti nel sonno e nell’umore. Molti studi confermano che le iniezioni di tossina botulinica di tipo A alleviano efficacemente l’emicrania cronica negli adulti; tuttavia, la letteratura sui bambini è scarsa. Questo studio mira ad analizzare la sicurezza e l’efficacia delle iniezioni di botulino di tipo A in un gruppo di pazienti pediatrici con diagnosi di emicrania cronica in una clinica del dolore pediatrico.

in questo studio retrospettivo (2013-2018), gli effetti delle iniezioni di tossina botulinica di tipo A sono stati analizzati utilizzando i dati di 65 pazienti pediatrici con diagnosi di emicrania cronica. Il gruppo di studio variava dagli 11 ai 18 anni di età. Un medico pediatrico per la gestione del dolore ha somministrato il botulino utilizzando il protocollo del programma di terapia di ricerca di fase 3 per la valutazione della profilassi dell’emicrania e ha seguito il modello del dolore. Sono stati misurati i dosaggi, la tolleranza e gli effetti collaterali.

ExoStd? Lyophilized Exosome Standard (100 µg, Human Urine, 4 vials)
M1045-4
EUR 1137
Exosome isolation Solution - Serum/ Plasma (easy version of P101, 95% pure exosome) sample
P101EZ--sample NULL
EUR 0
Rabbit Serum, Sterile, Non-hemolized (56-84 days old)
31125-4 1L
EUR 355
  • All products from Pel-Freez are available in Europe and worldwide via Gentaur. If you cannot find the item you need send us an inquiry and we will be in touch with you with pricing and delivery information in less than 12 hours.
Description: Produced from whole blood collected from young healthy rabbits (New Zealand White or Californian), 6+ months old. Pooled serum from male and female rabbits that are fasted prior to collection. The serum is processed, bottled, and stored at -20°C. Then the serum was thawed, pooled, passed through a 0.22-micron filter, bottled and returned to -20°C.
Thymus Dissociation System 3 (Epithelial), Rat, less than 6wk old
4-20443 ea Ask for price
Sample diluent buffer
AR1106-1 30ml
EUR 91
Exo-Urine EV Isolation Kit
EXOU100A-1 2 x 5 reactions
EUR 551
Rabbit Complement (21-28 days old rabbits)
31061-1 10mL
EUR 279
  • All products from Pel-Freez are available in Europe and worldwide via Gentaur. If you cannot find the item you need send us an inquiry and we will be in touch with you with pricing and delivery information in less than 12 hours.
Description: The complement is isolated from large pools of New Zealand White rabbits that are 21-28 days old and raised under strictly controlled conditions. This guarantees that the complement has low heterophile antibody activity for many applications, including use in bactericidal and opsonization assays. The complement is extremely heat-sensitive. Prior to working with it we recommend that the complement is thawed on ice or in a cold water bath or under a stream of cold water. Never thaw using warm or hot water. While defrosted like this we advise you to make single-use aliquots and keep them frozen at -70C. Freeze-thaw cycles will damage the complement components and will reduce significantly the activity. Once thawed, the leftover from a working aliquot should be discarded.
Urine protein 1
30R-AU008 1 mg
EUR 997
Description: Purified native Human Urine protein 1
RealScreen Pediatric FSH ELISA Kit
EL103-096 96T
EUR 1832
Pituitary Dissociation System 2 (Pituitary), Rat and mouse less than 2-month-old
4-20402 ea Ask for price
AGEs-BSA
KH001-A
EUR 870
Description: The AGEs-BSA is available in Europe and for worldwide shipping via Gentaur.
Epithelial Dissociation System 3 (Epithelial, < 10-day-old rat, Epithelial-like, Esophageal, Uterine), Rat
4-20253 ea Ask for price
Rabbit Serum, Sterile, Non-hemolized (56-84 days old)
31125-1 100mL
EUR 155
  • All products from Pel-Freez are available in Europe and worldwide via Gentaur. If you cannot find the item you need send us an inquiry and we will be in touch with you with pricing and delivery information in less than 12 hours.
Description: Produced from whole blood collected from young healthy rabbits (New Zealand White or Californian), 6+ months old. Pooled serum from male and female rabbits that are fasted prior to collection. The serum is processed, bottled, and stored at -20°C. Then the serum was thawed, pooled, passed through a 0.22-micron filter, bottled and returned to -20°C.
Rabbit Serum Sterile, trace-hemolized (56-84 days old)
31126-1 100mL
EUR 145
  • All products from Pel-Freez are available in Europe and worldwide via Gentaur. If you cannot find the item you need send us an inquiry and we will be in touch with you with pricing and delivery information in less than 12 hours.
Description: Produced from whole blood collected from young healthy rabbits (New Zealand White or Californian), 6+ months old. Pooled serum from male and female rabbits that are fasted prior to collection. The serum is processed, bottled, and stored at -20°C. Then the serum was thawed, pooled, passed through a 0.22-micron filter, bottled and returned to -20°C.
pBI121 old Plasmid
PVT3002 2 ug
EUR 370
ExoStep Urine
ExoS-25-U9 25 test
EUR 550.5
Rabbit Serum, Non-Sterile, Non-Hemolyzed (56-84 days old)
31118-1 100mL
EUR 145
  • All products from Pel-Freez are available in Europe and worldwide via Gentaur. If you cannot find the item you need send us an inquiry and we will be in touch with you with pricing and delivery information in less than 12 hours.
Description: Produced from whole blood collected from young healthy rabbits (New Zealand White or Californian), 6+ months old. Pooled serum from male and female rabbits that are fasted prior to collection. The serum is processed, bottled, and stored at -20°C.
Rabbit Serum, Non-Sterile, Trace-Hemolyzed (56-84 days old)
31119-1 100mL
EUR 138
  • All products from Pel-Freez are available in Europe and worldwide via Gentaur. If you cannot find the item you need send us an inquiry and we will be in touch with you with pricing and delivery information in less than 12 hours.
Description: Produced from whole blood collected from young healthy rabbits (New Zealand White or Californian), 6+ months old. Pooled serum from male and female rabbits that are fasted prior to collection. The serum is processed, bottled, and stored at -20°C.
Rabbit Plasma Non-Sterile, Sodium Citrate (56-84 days old)
31140-1 500mL
EUR 207
  • All products from Pel-Freez are available in Europe and worldwide via Gentaur. If you cannot find the item you need send us an inquiry and we will be in touch with you with pricing and delivery information in less than 12 hours.
Description: Whole blood is collected from young (8 - 12 weeks) healthy New Zealand White or Californian rabbits from both sexes and fasted prior to collection. The blood is mixed with 3.8% sodium citrate (25ml Na-Cit. per 250ml of the total volume). The plasma is separated from the blood cellular components by centrifugation. The plasma is pooled, bottled and stored at or below -10 °C.
Rabbit Plasma Non-Sterile K2 EDTA (56-84 days old)
31144-1 500mL
EUR 207
  • All products from Pel-Freez are available in Europe and worldwide via Gentaur. If you cannot find the item you need send us an inquiry and we will be in touch with you with pricing and delivery information in less than 12 hours.
Description: Whole blood is collected from young (8 - 12 weeks) healthy New Zealand White or Californian rabbits from both sexes and fasted prior to collection. The blood is mixed with 2.5 mL 15% K2 EDTA then QS to 250 mL with blood. The plasma is separated from the blood cellular components by centrifugation. The plasma is pooled, bottled and stored at or below -10 °C.
Rabbit Plasma Non-Sterile K3 EDTA (56-84 days old)
31145-1 500mL
EUR 186
  • All products from Pel-Freez are available in Europe and worldwide via Gentaur. If you cannot find the item you need send us an inquiry and we will be in touch with you with pricing and delivery information in less than 12 hours.
Description: Whole blood is collected from young (8 - 12 weeks) healthy New Zealand White or Californian rabbits from both sexes and fasted prior to collection. The blood is mixed with 2.5 mL 15% K3 EDTA then QS to 250 mL with blood. The plasma is separated from the blood cellular components by centrifugation. The plasma is pooled, bottled and stored at or below -10 °C.
AXYPREP MAG DYECLEAN KIT- 1 ML - (SAMPLE SIZE)
MAG-DYECL-1 1/pk
EUR 75
Description: Bioscience Mag Beads; Magnetic Dye
Purified Exosomes from Human Urine (Healthy Donors)
EXOP-520A-1 >25ug
EUR 477
  • Category: Exosomes
AXYPREP FRAGMENTSELECT-I KIT- 1 ML - (SAMPLE SIZE)
MAG-FRAG-I-1 1/pk
EUR 64
Description: Bioscience Mag Beads; Magnetic Fragment Select
ExoStepTM Urine + Standard
ExoS-25-UST9 25 test
EUR 726
Disposable yellow pipette tips (1-200 ul) for meat sample (1 box 96 tips)
YPT96-1 1 pk
EUR 61
All Sample Diluents Sample Pack
KF17355 3X100 ml
EUR 272
AXYPREP MAG PCR NORMALIZER KIT- 1 ML - (SAMPLE SIZE)
MAG-PCR-NM-1 1/pk
EUR 73
Description: Bioscience Mag Beads; Magnetic PCR Normaliser
Goat AGEs ELISA Kit
EGTA0009 96Tests
EUR 521
Chicken AGEs ELISA Kit
ECKA0009 96Tests
EUR 521
Anserini AGEs ELISA Kit
EAA0009 96Tests
EUR 521
Bovine AGEs ELISA Kit
EBA0009 96Tests
EUR 521
Mouse AGEs ELISA Kit
EMA0009 96Tests
EUR 521
Rat AGEs ELISA Kit
ERA0009 96Tests
EUR 521
Sheep AGEs ELISA Kit
ESA0009 96Tests
EUR 521
Rabbit AGEs ELISA Kit
ERTA0009 96Tests
EUR 521
Monkey AGEs ELISA Kit
EMKA0009 96Tests
EUR 521
Porcine AGEs ELISA Kit
EPA0009 96Tests
EUR 521
IL-4 Interleukin 4 Human Recombinant Protein, Yeast
PROTP05112-4 Regular: 10ug
EUR 317
Description: Interleukin-4 Human Recombinant produced in yeast is a single, glycosylated polypeptide chain containing 129 amino acids.;The IL-4 is purified by proprietary chromatographic techniques.
Sample Diluent
I094 1000 ml
EUR 519
  • Product category: Buffer solution
Description: Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.
Sample Diluent
I094-100 100 ml
EUR 211
  • Product category: Buffer solution
Description: Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.
Sample Diluent
I094-500 500 ml
EUR 373
  • Product category: Buffer solution
Description: Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.
AXYPREP MAG PCR CLEAN UP KIT- 1 ML - (SAMPLE SIZE)
MAG-PCR-CL-1 1/pk
EUR 58
Description: Bioscience Mag Beads; Magnetic PCR Clean Up
LH (Urine) ELISA Kit
DEIA2231 96T
EUR 559
Description: The LH (Urine) ELISA is an enzyme immunoassay for the quantitative in vitro diagnostic measurement of LH in urine. This test is used to detect the midcycle LH surge in urine, which is an aid in predicting the time of ovulation.
Fluorescent Exosome Standard (Urine )
ESF-15 100 µg
EUR 1723
Description: Fluorescent exosomes are labeled with green dye, which offer a stable fluorescent labeling.
Urine DNA Isolation Kit
K5011150 1 kit
EUR 256
ExoPure? Isolation Kit   (Urine)
K1240-10
EUR 697
ExoPure? Isolation Kit   (Urine)
K1240-2
EUR 403
Cystatin C, Human urine
P1447-100
EUR 338
Urine Creatinine Detection Kit
SKT-200-192 2 plates of 96 wells
EUR 342
  • Creatinine (2-amino-1-methyl-5H-imadazol-4-one) is a metabolite of phosphocreatine (p-creatine), a molecule used as a store for high-energy phosphate that can be utilized by tissues for the production of ATP (1). Creatine either comes from the diet o
  • Show more
Description: Direct Detection kit used for quantitative measuring creatinine in Urine samples from Human, Monkey, Dog, Rat
Individual Reaction Mix 4
G065-4 200 reactions
EUR 167
Human Cytokine Chemi (4-plex) Sample Demo Kit
MEK2001 Demo kit (Limit 1 kit per lab)
EUR 165
Human Cytokine Chemi (4-plex) Sample Demo Kit
MEK2001-96 Regular 96 Well
EUR 879
Human High Sensitivity (4-plex) Sample Demo Kit
MEK2002 Demo kit (Limit 1 kit per lab)
EUR 165
Human High Sensitivity (4-plex) Sample Demo Kit
MEK2002-96 Regular 96 Well
EUR 879
Mouse Cytokine Chemi (4-plex) Sample Demo Kit
MEK2003 Demo kit (Limit 1 kit per lab)
EUR 165
Mouse Cytokine Chemi (4-plex) Sample Demo Kit
MEK2003-96 Regular 96 Well
EUR 879
CORNING® GOSSELIN™ SAMPLE BLENDER 400ML, 230V
S-BLENDER-1 1/pk
EUR 2821
Description: Equipment; Gosselin Equipment
Human Complete SeraMir Exosome RNA Amplification and Profiling Kit for Media and Urine (contains cat# RA800A-1, RA805A-1, RA810A-1 and EXOTC50A-1 components)
RA820TC-1 20 profiles
EUR 1618
  • Category: MicroRNA Tools
Mouse Complete SeraMir Exosome RNA Amplification and Profiling Kit for Media and Urine (contains cat# RA800A-1, RA805A-1, RA810A-1 and EXOTC50A-1 components)
RA821TC-1 20 profiles
EUR 1618
  • Category: MicroRNA Tools
Guinea Pig AGEs ELISA Kit
EGA0009 96Tests
EUR 521
pLenti-CLDN1 shRNA-4 Plasmid
PVTBAV04867-4 2 ug
EUR 356
Feline IL-4 Recombinant Protein
R00230-4 5ug/vial
EUR 259
Description: IL-4 has many biological roles, including the stimulation of activated B-cell and T-cell proliferation, and the differentiation of CD4+ T-cells into Th2 cells. It is a key regulator in humoral and adaptive immunity. Feline IL-4 Recombinant Protein is purified interleukin-4 produced in yeast.
ExoStd? Lyophilized Exosome Standard (30 µg, BPH-1 cell line, 4 vials)
M1062-4
EUR 914
ExoStd? Lyophilized Exosome Standard (100 µg, BPH-1 cell line, 4 vials)
M1063-4
EUR 1142
CORNING® GOSSELIN™ SAMPLE DILUTER 400ML, 220V/110V
S-Diluter-1 1/pk
EUR 3955
Description: Equipment; Gosselin Equipment
Exendin 4 (1-8)
SP-100297-1 1 mg
EUR 225
DIGITAL SHAKER FOR 4 MICROPLATES, 120V
6780-4 1/pk
EUR 798
Description: Lab Equipment; Shakers & Mixers
Mouse FibrOut 4, for brain, neural
4-20507 1 ml Ask for price
Mouse FibrOut 4, for brain, neural
4-20508 5 x 1 ml Ask for price
Rat FibrOut 4, for brain, neural
4-20533 1 ml Ask for price
Rat FibrOut 4, for brain, neural
4-20534 5 x 1 ml Ask for price
Human FibrOut 4, for brain, neural
4-21552 1 ml Ask for price
Human FibrOut 4, for brain, neural
4-21553 5 x 1 ml Ask for price
Recombinant Human 4-1BB Receptor Protein
PROTQ07011-4 20ug
EUR 317
Description: 4-1BB Receptor, a member of the TNF superfamily of receptors, is mainly expressed on the surface of a variety of T cells, but also found in B cells, monocytes, and various transformed cell lines. 4-1BB Receptor binds to 4-1BBL to provide a co-stimulatory signal for T lymphocytes. Signaling by 4-1BB Receptor has been implicated in the antigen-presentation process and generation of cytotoxic T cells. The human 4-1BB Receptor gene codes for a 255 amino acid type I transmembrane protein containing a 17 amino acid N-terminal signal sequence, a 169 amino acid extracellular domain, a 27 amino acid transmembrane domain and a 42 amino acid cytoplasmic domain. Recombinant human soluble 4-1BB Receptor is a 167 amino acid polypeptide (17.7 kDa), which contains the cysteine rich TNFR-like extracellular domain of 4-1BB Receptor.
Recombinant Human PF-4 (CXCL4) Protein
PROTP02776-4 20ug
EUR 317
Description: PF-4 is a CXC chemokine that is expressed in megakaryocytes and stored in the α-granules of platelets. PF-4 is chemotactic towards neutrophils and monocytes and has been shown to inhibit angiogenesis. Recombinant human PF-4 is a 7.8 kDa protein containing 70 amino acid residues, including the four highly conserved residues present in CXC chemokines.
Rotavirus Positive Sample
DAG-H10377 1 ml dry ice
EUR 1105
RSV Positive Sample
DAG-H10378 1 ml dry ice
EUR 1105
DNA Sample Diluent
D006-100 100 ml
EUR 373
  • Product category: Buffer solution
Description: DNA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.
DNA Sample Diluent
D006-1000 1000 ml
EUR 1167
  • Product category: Buffer solution
Description: DNA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.
DNA Sample Diluent
D006-500 500 ml
EUR 726
  • Product category: Buffer solution
Description: DNA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.
Sample Diluent Buffer
abx296001-20ml 20 ml
EUR 91
  • Shipped within 5-10 working days.
BSA Sample Diluent
F031A 1000 ml
EUR 488
  • Product category: Buffer solution
Description: BSA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.
BSA Sample Diluent
F031A-100 100 ml
EUR 195
  • Product category: Buffer solution
Description: BSA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.
BSA Sample Diluent
F031A-500 500 ml
EUR 411
  • Product category: Buffer solution
Description: BSA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.
Sample Denaturing Buffer
F054 12 ml
EUR 195
  • Product category: Buffer solution
Description: Sample Denaturing Buffer by Cygnus Technologies is available in Europe via Gentaur.
Sample Treatment Buffer
F175 1000 ml
EUR 411
  • Product category: Buffer solution
Description: Sample Treatment Buffer by Cygnus Technologies is available in Europe via Gentaur.
Sample Treatment Buffer
F175-100 100 ml
EUR 219
  • Product category: Buffer solution
Description: Sample Treatment Buffer by Cygnus Technologies is available in Europe via Gentaur.
Sample Treatment Plate
F402 1x 96 wells plate
EUR 103
  • Product category: Microplates
Description: Sample Treatment Plate by Cygnus Technologies is available in Europe via Gentaur.
ELISA Sample Diluent
ESD125 125 ml
EUR 80
ELISA Sample Diluent
ESD500 500 ml
EUR 109
ELISA Sample Diluent
ESD999 1000 ml
EUR 157
Sample Diluent Buffer
I028-100 100 ml
EUR 211
  • Product category: Buffer solution
Description: Sample Diluent Buffer by Cygnus Technologies is available in Europe via Gentaur.
Sample Diluent Buffer
I028-1000 1000 ml
EUR 519
  • Product category: Buffer solution
Description: Sample Diluent Buffer by Cygnus Technologies is available in Europe via Gentaur.
Sample Diluent Buffer
I028-500 500 ml
EUR 373
  • Product category: Buffer solution
Description: Sample Diluent Buffer by Cygnus Technologies is available in Europe via Gentaur.
HEPES Sample Diluent
I050 1000 ml
EUR 527
  • Product category: Buffer solution
Description: HEPES Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.
HEPES Sample Diluent
I050-100 100 ml
EUR 219
  • Product category: Buffer solution
Description: HEPES Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.
HEPES Sample Diluent
I050-500 500 ml
EUR 334
  • Product category: Buffer solution
Description: HEPES Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

in questo studio, il 74% dei pazienti ha provato più di 6 farmaci prima delle iniezioni. C’è stata una diminuzione nel punteggio della scala analogica visiva di 5,2 ± 2,2 punti dopo 6 settimane di follow-up. La quantità media di farmaco utilizzata è stata di 173,2 ± 35 unità e i pazienti hanno ricevuto una media di 2,8 ± 1,1 unità / kg. Gli eventi avversi includono un paziente che ha sviluppato capogiri e un altro che ha avuto febbri di basso grado con ingrossamento dei linfonodi cervicali; entrambi risolti in pochi minuti.
Conclusioni: questo studio supporta l’uso del tipo botulinico